US researchers have begun a groundbreaking trial to test the potential of umbilical cord blood transplants, a kind of stem cell therapy, to treat and possibly reverse hearing loss in infants.
Papildomos nuorodos
U.S. begins stem cell trial for hearing loss
Šis įrašas paskelbtas Kamieninių ląstelių tyrimai kategorijose.
